Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Sartorius Launches New Lab Balance on the Market
Wednesday, April 16, 2014
Quintix® is a user-friendly, highly accurate standard laboratory balance, redefining the meaning of easy for standard lab applications.

Cancer Researcher Wins Cytation™ 3 in BioTek's Contest!
Saturday, April 12, 2014
Dr. Jeff Peterson wins Cytation™ 3 cell imaging multi-mode reader in "Think Possible" Application Contest.

Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

Life Technologies Releases New Research Tool
Tuesday, April 08, 2014
Oncomine NGS RNA-Seq Gene Expression Browser extends the Oncomine NGS Power Tools product offering.

Horizon Launches New GENASSIST CRISPR and rAAV Gene Editing Tools and Services
Tuesday, April 08, 2014
Comprehensive product and service solution enables easier, robust implementation of gene editing experiments in customer’s hands.

Bio-Rad’s Droplet Digital™ PCR Technology Highlighted at the 2014 AACR Annual Meeting
Tuesday, April 08, 2014
Introduced less than three years ago, ddPCR is rapidly gaining acceptance within the cancer research community. In fact, from 2012 to 2013, the number of cancer research papers involving ddPCR has nearly quintupled.

Advancing High-Content Analysis for Cancer Applications
Tuesday, April 08, 2014
A new high-content screening software platform enables cancer researchers to uncover more about basic and advanced cellular function to accelerate cell-based research.

InSphero to Distribute Dainippon Screen Imager for Rapid Profiling of 3D Microtissues
Tuesday, April 08, 2014
The Cell'iMager, to be marketed in the US and Europe, simplifies growth and morphological profiling of 3D microtissues.

Horizon Discovery Launches New Gene Editing Tools and Services
Monday, April 07, 2014
The comprehensive product and service solution enables easier, robust implementation of gene editing experiments in customer’s hands.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 2496
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv